Smith Nicholas Conrad bought ANRO
February 6, 2024 · Form 4 insider transaction
Smith Nicholas Conrad bought 1,563 shares of Alto Neuroscience, Inc. at $16.00 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,563
Price
$16.00
Total value
$25.0K
InsiderSmith Nicholas Conrad
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 6, 2024
Filing dateFebruary 7, 2024
Shares owned after1,563
OwnershipDirect
10b5-1 planNo
AmendedNo